| Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: Results from the A(1)chieve study. | |
| | |
MedLine Citation:
|
PMID: 23217267 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Aims: This A1chieve® study subgroup analysis examined clinical safety and effectiveness of biphasic insulin aspart 30 (BIAsp30) ±OGLDs in 6323 individuals with T2D, switching from biphasic human insulin 30 (BHI30) ±OGLDs. Methods: A1chieve was a 24-week, international, prospective, observational, multi-centre, open-label study in individuals with T2D starting treatment with BIAsp30, insulin detemir or insulin aspart as part of routine clinical care. Results: Mean baseline (SD) dose BHI was 0.56 (0.25) IU/kg. BIAsp30 was initiated at 0.57 (0.25) U/kg; the daily dose was 0.62 (0.28)U/kg by Week 24. Switching from BHI30 to BIAsp30 was associated with significant mean reduction in HbA1c of 1.7% [-18 mmol/mol] (1.6) from a baseline of 9.1% [76 mmol/mol] (p<0.001); FPG and PPG were also significantly reduced (p<0.001). Major hypoglycaemic episodes decreased from 0.69 events/patient/year at baseline to 0.03 events/patient/year at Week 24. Minor hypoglycaemia decreased from 5.31 to 2.04 events/patient/year from baseline to study-end. Five serious adverse drug reactions (hypoglycaemia) were reported by five individuals (0.1%). Mean bodyweight increased by 0.1 (3.3)kg from baseline to 24 weeks. Improved self-reported quality of life was observed. Conclusion: Switching from BHI30 to BIAsp30 in individuals with T2D is associated with improvement in glycaemic control and reduced rates of hypoglycaemia, without tolerability or safety issues. Clinical trial registration: Clinicaltrials.gov, NCT00869908. |
| | |
Authors:
|
Nabil K El Naggar; Pradana Soewondo; Mohammad E Khamseh; Jian-Wen Chen; Jihad Haddad |
Related Documents
:
|
8163287 - Association of phenylthiocarbamide taste sensitivity with diabetes mellitus in bangladesh. 10476087 - A nursing screening program for diabetes in northern new mexico. 23137497 - Modulating peroxisome proliferator-activated receptors for therapeutic benefit? biology... 8911777 - Detection of sight-threatening diabetic eye disease. 8138067 - The squatting test. a useful tool to assess both parasympathetic and sympathetic involv... 9032097 - Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cho... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Diabetes research and clinical practice Volume: 98 ISSN: 1872-8227 ISO Abbreviation: Diabetes Res. Clin. Pract. Publication Date: 2012 Dec |
Date Detail:
|
Created Date: 2012-12-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8508335 Medline TA: Diabetes Res Clin Pract Country: Ireland |
Other Details:
|
Languages: eng Pagination: 408-13 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Hai Al Jamea Hospital, Jeddah, Jeddah 21433, The Kingdom of Saudi Arabia. Electronic address: nelnaggar@yahoo.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Meta-analysis identified the TNFA -308G>A promoter polymorphism as a risk factor for disease severit...
Next Document: Double J stent of frontal sinus outflow tract in revision frontal sinus surgery.